Search details
1.
Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet
; 402(10407): 1043-1051, 2023 09 23.
Article
in English
| MEDLINE | ID: mdl-37524096
2.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36382533
3.
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium.
J Urol
; 209(4): 701-709, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36573926
4.
Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study.
Cancer
; 128(6): 1194-1205, 2022 Mar 15.
Article
in English
| MEDLINE | ID: mdl-34882781
5.
Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
Cancer
; 127(12): 1965-1973, 2021 06 15.
Article
in English
| MEDLINE | ID: mdl-33690902
6.
A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18F-DCFPyL in Prostate Cancer Patients (OSPREY).
J Urol
; 206(1): 52-61, 2021 07.
Article
in English
| MEDLINE | ID: mdl-33634707
7.
A randomized phase 2 trial of pembrolizumab versus pembrolizumab and acalabrutinib in patients with platinum-resistant metastatic urothelial cancer.
Cancer
; 126(20): 4485-4497, 2020 10 15.
Article
in English
| MEDLINE | ID: mdl-32757302
8.
Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial.
Cancer
; 126(18): 4156-4167, 2020 09 15.
Article
in English
| MEDLINE | ID: mdl-32673417
9.
Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma.
Invest New Drugs
; 37(2): 323-330, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30393825
10.
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy.
Br J Cancer
; 119(7): 801-807, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30293995
12.
Novel Approaches with HIF-2α Targeted Therapies in Metastatic Renal Cell Carcinoma.
Cancers (Basel)
; 16(3)2024 Jan 31.
Article
in English
| MEDLINE | ID: mdl-38339352
13.
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
JCO Precis Oncol
; 8: e2300406, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38603651
14.
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations.
JCO Precis Oncol
; 8: e2300567, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38579192
15.
Pathogenic Germline Mutational Landscape in Patients With Renal Cell Carcinoma and Associated Clinicopathologic Features.
JCO Precis Oncol
; 7: e2300168, 2023 09.
Article
in English
| MEDLINE | ID: mdl-38127826
16.
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study.
J Clin Oncol
; 41(33): 5140-5150, 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37561967
17.
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol
; 2023 Dec 09.
Article
in English
| MEDLINE | ID: mdl-38072760
18.
Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer.
JAMA Netw Open
; 6(9): e2334208, 2023 09 05.
Article
in English
| MEDLINE | ID: mdl-37721753
19.
IL-4 induces proliferation in prostate cancer PC3 cells under nutrient-depletion stress through the activation of the JNK-pathway and survivin up-regulation.
J Cell Biochem
; 113(5): 1569-80, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22174091
20.
Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a multidisciplinary approach.
Cancer
; 118(1): 44-53, 2012 Jan 01.
Article
in English
| MEDLINE | ID: mdl-21598245